Home/Filings/4/0001437749-22-001917
4//SEC Filing

Hornung William Karl 4

Accession 0001437749-22-001917

CIK 0001053691other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 6:08 AM ET

Size

5.4 KB

Accession

0001437749-22-001917

Insider Transaction Report

Form 4
Period: 2022-01-27
Hornung William Karl
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-27+305,743305,743 total
    Exercise: $0.24Exp: 2032-01-27Common Stock (305,743 underlying)
Footnotes (1)
  • [F1]The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2022.

Issuer

Diffusion Pharmaceuticals Inc.

CIK 0001053691

Entity typeother

Related Parties

1
  • filerCIK 0001612066

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 6:08 AM ET
Size
5.4 KB